$GEB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INOVIO PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INOVIO PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INOVIO PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 27 2014 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 3.23 | 300,000 | 969,000 | 300,000 | |
Mar 27 2014 | GEB | INOVIO PHARMACEUTI ... | Sardesai Niranjan | Chief Operating Off ... | Option Exercise | A | 3.23 | 150,000 | 484,500 | 150,000 | |
Nov 14 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 1.82 | 25,000 | 45,513 | 75,000 | 50 K to 75 K (+50.00 %) |
Nov 14 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 1.82 | 25,000 | 45,513 | 75,000 | 50 K to 75 K (+50.00 %) |
Nov 14 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 1.82 | 3,500 | 6,372 | 3,500 | 0 to 3.5 K |
Nov 14 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 1.82 | 11,000 | 20,026 | 11,000 | 0 to 11 K |
Nov 14 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 1.82 | 50,000 | 91,025 | 655,864 | 605.9 K to 655.9 K (+8.25 %) |
Nov 14 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 1.82 | 40,000 | 72,820 | 605,864 | 565.9 K to 605.9 K (+7.07 %) |
Nov 14 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 1.82 | 100,000 | 182,050 | 565,864 | 465.9 K to 565.9 K (+21.47 %) |
May 20 2013 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.67 | 40,000 | 26,800 | 40,000 | |
May 20 2013 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 0.67 | 40,000 | 26,800 | 40,000 | |
May 20 2013 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Option Exercise | A | 0.67 | 40,000 | 26,800 | 40,000 | |
May 20 2013 | GEB | INOVIO PHARMACEUTI ... | MAHMOUD ADEL | Director | Option Exercise | A | 0.67 | 40,000 | 26,800 | 40,000 | |
May 20 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.67 | 40,000 | 26,800 | 40,000 | |
Apr 16 2013 | GEB | INOVIO PHARMACEUTI ... | Bagarazzi Mark | Chief Medical Offic ... | Buy | P | 0.56 | 60,000 | 33,540 | 60,000 | 0 to 60 K |
Apr 02 2013 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.50 | 90,000 | 45,180 | 11,940,809 | 11.9 M to 11.9 M (+0.76 %) |
Mar 22 2013 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Buy | P | 0.54 | 40,000 | 21,592 | 115,000 | 75 K to 115 K (+53.33 %) |
Mar 22 2013 | GEB | INOVIO PHARMACEUTI ... | Sardesai Niranjan | Chief Operating Off ... | Buy | P | 0.53 | 25,000 | 13,328 | 101,800 | 76.8 K to 101.8 K (+32.55 %) |
Mar 20 2013 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.53 | 60,000 | 31,680 | 11,850,809 | 11.8 M to 11.9 M (+0.51 %) |
Mar 18 2013 | GEB | INOVIO PHARMACEUTI ... | Bagarazzi Mark | Chief Medical Offic ... | Option Exercise | A | 0.54 | 180,000 | 97,200 | 180,000 | |
Mar 18 2013 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 0.54 | 430,000 | 232,200 | 430,000 | |
Mar 18 2013 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.54 | 180,000 | 97,200 | 180,000 | |
Mar 18 2013 | GEB | INOVIO PHARMACEUTI ... | Sardesai Niranjan | Chief Operating Off ... | Option Exercise | A | 0.54 | 180,000 | 97,200 | 180,000 | |
Jan 16 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 0.67 | 50,000 | 33,470 | 50,000 | 0 to 50 K |
Jan 16 2013 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 0.67 | 50,000 | 33,470 | 50,000 | 0 to 50 K |
Jan 08 2013 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.53 | 50,000 | 26,495 | 134,130 | 84.1 K to 134.1 K (+59.43 %) |
Jan 08 2013 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.53 | 50,000 | 26,495 | 134,250 | 84.3 K to 134.3 K (+59.35 %) |
Jan 08 2013 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.53 | 50,000 | 26,495 | 135,100 | 85.1 K to 135.1 K (+58.75 %) |
Jan 08 2013 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.53 | 150,000 | 79,485 | 11,790,809 | 11.9 M to 11.8 M (-1.26 %) |
Nov 28 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.49 | 650,000 | 318,370 | 4,552,206 | 5.2 M to 4.6 M (-12.49 %) |
Nov 28 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.47 | 300,000 | 141,180 | 5,202,206 | 5.5 M to 5.2 M (-5.45 %) |
Dec 04 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.55 | 25,000 | 13,750 | 3,919,706 | 3.9 M to 3.9 M (-0.63 %) |
Nov 30 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.55 | 92,800 | 51,040 | 3,944,706 | 4 M to 3.9 M (-2.30 %) |
Nov 30 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.55 | 250,000 | 137,075 | 4,037,506 | 4.3 M to 4 M (-5.83 %) |
Nov 30 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.54 | 168,700 | 91,216 | 4,287,506 | 4.5 M to 4.3 M (-3.79 %) |
Nov 30 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.57 | 96,000 | 54,394 | 4,456,206 | 4.6 M to 4.5 M (-2.11 %) |
Nov 26 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.47 | 123,900 | 58,691 | 5,502,206 | 5.6 M to 5.5 M (-2.20 %) |
Nov 26 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.47 | 230,000 | 108,744 | 5,626,106 | 5.9 M to 5.6 M (-3.93 %) |
Nov 20 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.47 | 126,800 | 59,976 | 5,856,106 | 6 M to 5.9 M (-2.12 %) |
Nov 20 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.48 | 220,099 | 105,075 | 5,982,906 | 6.2 M to 6 M (-3.55 %) |
Nov 19 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.48 | 500,000 | 241,800 | 6,203,005 | 6.7 M to 6.2 M (-7.46 %) |
Nov 19 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.46 | 500,000 | 232,300 | 6,703,005 | 7.2 M to 6.7 M (-6.94 %) |
Nov 15 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.52 | 400,000 | 208,840 | 7,203,005 | 7.6 M to 7.2 M (-5.26 %) |
Nov 15 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.54 | 222,550 | 120,199 | 7,603,005 | 7.8 M to 7.6 M (-2.84 %) |
Nov 13 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.57 | 148,192 | 85,033 | 7,825,555 | 8 M to 7.8 M (-1.86 %) |
Nov 13 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.57 | 400,000 | 229,760 | 7,973,747 | 8.4 M to 8 M (-4.78 %) |
Nov 13 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.61 | 500,000 | 306,200 | 8,373,747 | 8.9 M to 8.4 M (-5.63 %) |
Nov 05 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.72 | 31,979 | 23,025 | 8,873,747 | 8.9 M to 8.9 M (-0.36 %) |
Oct 29 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.72 | 9,788 | 7,047 | 8,905,726 | 8.9 M to 8.9 M (-0.11 %) |
Oct 26 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.72 | 10,250 | 7,383 | 8,915,514 | 8.9 M to 8.9 M (-0.11 %) |
Oct 26 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.73 | 2,900 | 2,103 | 8,925,764 | 8.9 M to 8.9 M (-0.03 %) |
Oct 24 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.42 | 202,000 | 286,416 | 8,928,664 | 9.1 M to 8.9 M (-2.21 %) |
Oct 24 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.72 | 100,000 | 71,500 | 9,130,664 | 9.2 M to 9.1 M (-1.08 %) |
Oct 16 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.72 | 20,286 | 14,504 | 9,230,664 | 9.3 M to 9.2 M (-0.22 %) |
Oct 16 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.72 | 13,400 | 9,581 | 9,250,950 | 9.3 M to 9.3 M (-0.14 %) |
Oct 12 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.72 | 169,700 | 121,556 | 9,264,350 | 9.4 M to 9.3 M (-1.80 %) |
Oct 12 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.70 | 75,200 | 53,008 | 9,434,050 | 9.5 M to 9.4 M (-0.79 %) |
Oct 12 2012 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.72 | 319,000 | 229,744 | 9,509,250 | 9.8 M to 9.5 M (-3.25 %) |
Aug 16 2012 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Buy | P | 0.59 | 75,000 | 44,250 | 75,000 | 0 to 75 K |
Aug 13 2012 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.55 | 40,000 | 22,000 | 40,000 | |
Aug 13 2012 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 0.55 | 40,000 | 22,000 | 40,000 | |
Aug 13 2012 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.55 | 40,000 | 22,000 | 40,000 | |
Jun 18 2012 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Option Exercise | A | 0.40 | 75,000 | 30,000 | 75,000 | |
Jun 13 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.41 | 15,000 | 6,090 | 11,940,809 | 11.9 M to 11.9 M (+0.13 %) |
Jun 06 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.41 | 25,000 | 10,250 | 11,925,809 | 11.9 M to 11.9 M (+0.21 %) |
Jun 05 2012 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | P | 0.41 | 25,000 | 10,250 | 69,712 | 44.7 K to 69.7 K (+55.91 %) |
May 17 2012 | GEB | INOVIO PHARMACEUTI ... | Sardesai Niranjan | Chief Operating Off ... | Buy | P | 0.45 | 10,000 | 4,500 | 76,800 | 66.8 K to 76.8 K (+14.97 %) |
May 10 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.48 | 50,000 | 24,000 | 11,900,809 | 11.9 M to 11.9 M (+0.42 %) |
Mar 27 2012 | GEB | INOVIO PHARMACEUTI ... | MAHMOUD ADEL | Director | Option Exercise | A | 0.62 | 75,000 | 46,500 | 75,000 | |
Mar 23 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.62 | 19,116 | 11,823 | 11,850,809 | 11.8 M to 11.9 M (+0.16 %) |
Mar 23 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.62 | 30,884 | 19,055 | 11,831,693 | 11.8 M to 11.8 M (+0.26 %) |
Mar 06 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.00 | 45,600 | 0 | 84,130 | 38.5 K to 84.1 K (+118.35 %) |
Mar 06 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.00 | 45,600 | 0 | 84,250 | 38.7 K to 84.3 K (+117.98 %) |
Mar 06 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.00 | 45,600 | 0 | 85,100 | 39.5 K to 85.1 K (+115.44 %) |
Mar 06 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.00 | 136,800 | 0 | 11,800,809 | 11.9 M to 11.8 M (-1.15 %) |
Feb 27 2012 | GEB | INOVIO PHARMACEUTI ... | Bagarazzi Mark | Chief Medical Offic ... | Option Exercise | A | 0.60 | 175,000 | 105,000 | 175,000 | |
Feb 27 2012 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.60 | 175,000 | 105,000 | 175,000 | |
Feb 27 2012 | GEB | INOVIO PHARMACEUTI ... | Sardesai Niranjan | Chief Operating Off ... | Option Exercise | A | 0.60 | 175,000 | 105,000 | 175,000 | |
Feb 27 2012 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 0.60 | 415,000 | 249,000 | 415,000 | |
Jan 04 2012 | GEB | INOVIO PHARMACEUTI ... | Sardesai Niranjan | Chief Operating Off ... | Option Exercise | A | 0.44 | 50,000 | 22,000 | 50,000 | |
Dec 15 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.38 | 535,000 | 204,584 | 9,828,250 | 10.4 M to 9.8 M (-5.16 %) |
Dec 13 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.39 | 360,000 | 139,248 | 10,363,250 | 10.7 M to 10.4 M (-3.36 %) |
Dec 13 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.40 | 400,000 | 158,120 | 10,723,250 | 11.1 M to 10.7 M (-3.60 %) |
Dec 09 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.40 | 503,000 | 202,508 | 11,123,250 | 11.6 M to 11.1 M (-4.33 %) |
Dec 09 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.40 | 300,000 | 119,730 | 11,626,250 | 11.9 M to 11.6 M (-2.52 %) |
Dec 07 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.42 | 100,000 | 42,000 | 11,926,250 | 12 M to 11.9 M (-0.83 %) |
Dec 07 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.41 | 150,000 | 61,500 | 12,026,250 | 12.2 M to 12 M (-1.23 %) |
Dec 07 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.44 | 45,200 | 19,888 | 12,176,250 | 12.2 M to 12.2 M (-0.37 %) |
Dec 05 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.43 | 250,000 | 107,500 | 12,221,450 | 12.5 M to 12.2 M (-2.00 %) |
Dec 05 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.42 | 170,000 | 72,063 | 12,471,450 | 12.6 M to 12.5 M (-1.34 %) |
Dec 05 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.43 | 570,000 | 244,245 | 12,641,450 | 13.2 M to 12.6 M (-4.31 %) |
Dec 05 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.43 | 670,000 | 286,224 | 13,211,450 | 13.9 M to 13.2 M (-4.83 %) |
Oct 19 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.60 | 1,500 | 900 | 13,881,450 | 13.9 M to 13.9 M (-0.01 %) |
Oct 19 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.62 | 2,800 | 1,736 | 13,882,950 | 13.9 M to 13.9 M (-0.02 %) |
Oct 13 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.60 | 19,950 | 12,016 | 13,885,750 | 13.9 M to 13.9 M (-0.14 %) |
Oct 13 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.60 | 8,900 | 5,383 | 13,905,700 | 13.9 M to 13.9 M (-0.06 %) |
Oct 11 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.62 | 23,500 | 14,570 | 13,914,600 | 13.9 M to 13.9 M (-0.17 %) |
Oct 11 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.60 | 200,000 | 120,000 | 13,914,600 | 14.1 M to 13.9 M (-1.42 %) |
Oct 05 2011 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | P | 0.54 | 18,000 | 9,630 | 18,000 | 0 to 18 K |
Oct 05 2011 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | P | 0.50 | 16,250 | 8,125 | 44,712 | 28.5 K to 44.7 K (+57.09 %) |
Oct 05 2011 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | P | 0.51 | 2,900 | 1,479 | 28,462 | 25.6 K to 28.5 K (+11.34 %) |
Oct 04 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.56 | 25,000 | 14,000 | 11,937,609 | 11.9 M to 11.9 M (+0.21 %) |
Oct 04 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.57 | 200,000 | 113,300 | 14,138,100 | 14.3 M to 14.1 M (-1.39 %) |
Sep 30 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.57 | 400,000 | 228,560 | 14,338,100 | 14.7 M to 14.3 M (-2.71 %) |
Sep 30 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.59 | 72,300 | 42,585 | 14,738,100 | 14.8 M to 14.7 M (-0.49 %) |
Sep 30 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.58 | 141,000 | 82,386 | 14,810,400 | 15 M to 14.8 M (-0.94 %) |
Sep 28 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.62 | 180,000 | 111,960 | 14,951,400 | 15.1 M to 15 M (-1.19 %) |
Sep 28 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.62 | 76,000 | 47,204 | 15,131,400 | 15.2 M to 15.1 M (-0.50 %) |
Sep 26 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.63 | 202,000 | 126,937 | 15,207,400 | 15.4 M to 15.2 M (-1.31 %) |
Sep 26 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.66 | 166,000 | 108,896 | 15,409,400 | 15.6 M to 15.4 M (-1.07 %) |
Sep 06 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.69 | 10,000 | 6,900 | 11,912,609 | 11.9 M to 11.9 M (+0.08 %) |
Sep 06 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.70 | 31,887 | 22,448 | 11,902,609 | 11.9 M to 11.9 M (+0.27 %) |
Aug 29 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.66 | 11,871 | 7,835 | 38,530 | 26.7 K to 38.5 K (+44.53 %) |
Aug 29 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.66 | 3,650 | 2,409 | 38,650 | 35 K to 38.7 K (+10.43 %) |
Aug 29 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.66 | 4,500 | 2,970 | 39,500 | 35 K to 39.5 K (+12.86 %) |
Aug 25 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.67 | 26,659 | 17,755 | 26,659 | 0 to 26.7 K |
Aug 25 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.67 | 35,000 | 23,310 | 35,000 | 0 to 35 K |
Aug 25 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.66 | 15,000 | 9,830 | 35,000 | 20 K to 35 K (+75.00 %) |
Aug 25 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.65 | 20,000 | 12,928 | 20,000 | 0 to 20 K |
Aug 24 2011 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 0.66 | 50,000 | 32,815 | 465,864 | 415.9 K to 465.9 K (+12.02 %) |
Aug 15 2011 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 0.63 | 50,000 | 31,495 | 415,864 | 365.9 K to 415.9 K (+13.67 %) |
Jul 06 2011 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Executive Chairman | Buy | P | 0.72 | 20,000 | 14,400 | 233,332 | 213.3 K to 233.3 K (+9.38 %) |
Jul 05 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.61 | 1,500,000 | 915,150 | 15,575,400 | 17.1 M to 15.6 M (-8.78 %) |
Jun 29 2011 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 0.59 | 50,000 | 29,300 | 365,864 | 315.9 K to 365.9 K (+15.83 %) |
Jun 30 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.59 | 500,000 | 295,050 | 17,075,400 | 17.6 M to 17.1 M (-2.84 %) |
Jun 30 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.58 | 2,000,000 | 1,154,600 | 17,575,400 | 19.6 M to 17.6 M (-10.22 %) |
Jun 27 2011 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Buy | P | 0.57 | 20,000 | 11,312 | 27,189 | 7.2 K to 27.2 K (+278.20 %) |
Jun 27 2011 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 0.58 | 100,000 | 57,610 | 315,864 | 215.9 K to 315.9 K (+46.33 %) |
Jun 24 2011 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | P | 0.57 | 24,000 | 13,622 | 25,562 | 1.6 K to 25.6 K (+1,536.49 %) |
Jun 20 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.63 | 21,900 | 13,688 | 15,433,202 | 15.4 M to 15.4 M (+0.14 %) |
Jun 20 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 0.63 | 27,450 | 17,156 | 15,433,202 | 15.4 M to 15.4 M (+0.18 %) |
May 17 2011 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 0.89 | 35,000 | 31,150 | 35,000 | |
May 17 2011 | GEB | INOVIO PHARMACEUTI ... | Wells Keith H | Director | Option Exercise | A | 0.89 | 35,000 | 31,150 | 35,000 | |
May 17 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.92 | 250,000 | 230,000 | 19,575,400 | 19.8 M to 19.6 M (-1.26 %) |
May 17 2011 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.89 | 35,000 | 31,150 | 35,000 | |
May 13 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.92 | 100,000 | 92,490 | 19,825,400 | 19.9 M to 19.8 M (-0.50 %) |
May 11 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 0.91 | 200,000 | 182,440 | 19,925,400 | 20.1 M to 19.9 M (-0.99 %) |
Apr 20 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.00 | 250,000 | 250,600 | 20,125,400 | 20.4 M to 20.1 M (-1.23 %) |
Apr 01 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.17 | 250,000 | 292,500 | 20,375,400 | 20.6 M to 20.4 M (-1.21 %) |
Mar 14 2011 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 1.14 | 250,000 | 285,000 | 250,000 | |
Mar 14 2011 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Executive Chairman | Option Exercise | A | 1.14 | 150,000 | 171,000 | 150,000 | |
Mar 14 2011 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 1.14 | 120,000 | 136,800 | 120,000 | |
Feb 04 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.36 | 105,000 | 143,010 | 20,625,400 | 20.7 M to 20.6 M (-0.51 %) |
Feb 04 2011 | GEB | INOVIO PHARMACEUTI ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.34 | 400,000 | 536,440 | 20,730,400 | 21.1 M to 20.7 M (-1.89 %) |
Jun 18 2010 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 1.15 | 35,000 | 40,250 | 35,000 | |
Jun 18 2010 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 1.15 | 35,000 | 40,250 | 35,000 | |
Jun 18 2010 | GEB | INOVIO PHARMACEUTI ... | Williams David J | Director | Option Exercise | A | 1.15 | 35,000 | 40,250 | 35,000 | |
Jun 18 2010 | GEB | INOVIO PHARMACEUTI ... | Wells Keith H | Director | Option Exercise | A | 1.15 | 35,000 | 40,250 | 35,000 | |
Nov 18 2009 | GEB | INOVIO PHARMACEUTI ... | Rassas Kevin | Sr. VP Business Dev ... | Option Exercise | M | 0.31 | 117,744 | 36,006 | 0 | |
Nov 18 2009 | GEB | INOVIO PHARMACEUTI ... | Rassas Kevin | Sr. VP Business Dev ... | Option Exercise | M | 0.20 | 392,480 | 79,987 | 0 |